Cellectar Biosciences, Inc. Financing Cash Flow
Cellectar Biosciences, Inc. (CLRB) reported Financing Cash Flow of $31.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.99M.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $5.79M, a 67.04% decline year-over-year.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $17.56M, a 21.94% decline year-over-year.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $13.03M, a 78.78% decline from fiscal 2024.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $61.41M, a 167.71% increase from fiscal 2023.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $22.94M, a 138.69% increase from fiscal 2022.
- Cellectar Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $9.61M, a 669.59% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 104 month | Net Cash Provided by (Used in) Financing Activities 107 month | Net Cash Provided by (Used in) Financing Activities 110 month | Net Cash Provided by (Used in) Financing Activities 113 month | Net Cash Provided by (Used in) Financing Activities 116 month | Net Cash Provided by (Used in) Financing Activities 119 month | Net Cash Provided by (Used in) Financing Activities 122 month | Net Cash Provided by (Used in) Financing Activities 125 month | Net Cash Provided by (Used in) Financing Activities 128 month | Net Cash Provided by (Used in) Financing Activities 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.66M 10-Q · filed 2026-08-13 | |||||||||||||
| 2025-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $10.78M derived: sum of 2 quarters · filed 2026-03-04 | $13.03M 10-K · filed 2026-03-04 | |||||||||||
| 2025-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $8.04M 10-Q · filed 2025-11-13 | ||||||||||||
| 2025-06-30 | $2.25M 10-Q · filed 2026-08-13 | |||||||||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $17.56M derived: sum of 2 quarters · filed 2026-03-04 | $17.56M derived: sum of 3 quarters · filed 2026-03-04 | $61.41M 10-K · filed 2026-03-04 | ||||||||||
| 2024-09-30 | $17.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $17.56M derived: sum of 2 quarters · filed 2025-11-13 | $61.41M 10-Q · filed 2025-11-13 | $61.85M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||
| 2024-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $43.85M 10-Q · filed 2025-08-14 | $44.29M derived: sum of 3 quarters · filed 2025-08-14 | $66.79M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||
| 2024-03-31 | $43.85M 10-Q · filed 2025-05-13 | $44.29M derived: sum of 2 quarters · filed 2025-05-13 | $66.79M derived: sum of 3 quarters · filed 2025-05-13 | $66.79M derived: sum of 4 quarters · filed 2025-05-13 | ||||||||||
| 2023-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $22.94M derived: sum of 2 quarters · filed 2025-03-13 | $22.94M derived: sum of 3 quarters · filed 2025-03-13 | $22.94M 10-K · filed 2025-03-13 | ||||||||||
| 2023-09-30 | $22.50M derived: 10-Q 9 month − 10-K/A 6 month · filed 2024-11-18 | $22.50M derived: sum of 2 quarters · filed 2024-11-18 | $22.50M 10-Q · filed 2024-11-18 | |||||||||||
| 2023-06-30 | $0.00 derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-10-29 | $3.00 10-K/A · filed 2024-10-29 | ||||||||||||
| 2023-03-31 | $3.00 10-K/A · filed 2024-10-29 | |||||||||||||
| 2022-12-31 | $9.61M 10-K/A · filed 2024-10-29 | |||||||||||||
| 2021-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.00 derived: sum of 2 quarters · filed 2023-03-09 | $34.87K derived: sum of 3 quarters · filed 2023-03-09 | $1.25M 10-K · filed 2023-03-09 | ||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $34.87K derived: sum of 2 quarters · filed 2022-11-03 | $1.25M 10-Q · filed 2022-11-03 | $43.46M derived: sum of 4 quarters · filed 2022-11-03 | ||||||||||
| 2021-06-30 | $34.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.25M 10-Q · filed 2022-08-05 | $43.46M derived: sum of 3 quarters · filed 2022-08-05 | $43.35M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||||
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-10 | $43.42M derived: sum of 2 quarters · filed 2022-05-10 | $43.32M derived: sum of 3 quarters · filed 2022-05-10 | $61.76M derived: sum of 4 quarters · filed 2022-05-10 | ||||||||||
| 2020-12-31 | $42.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $42.10M derived: sum of 2 quarters · filed 2022-03-21 | $60.55M derived: sum of 3 quarters · filed 2022-03-21 | $60.55M 10-K · filed 2022-03-21 | ||||||||||
| 2020-09-30 | -$106.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $18.34M derived: sum of 2 quarters · filed 2021-11-08 | $18.34M 10-Q · filed 2021-11-08 | $18.34M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||
| 2020-06-30 | $18.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $18.44M 10-Q · filed 2021-08-09 | $18.44M derived: sum of 3 quarters · filed 2021-08-09 | $18.44M derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-02 | -$568.00 derived: sum of 3 quarters · filed 2021-03-02 | $9.02M derived: sum of 4 quarters · filed 2021-03-02 | ||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$568.00 derived: sum of 2 quarters · filed 2021-03-02 | $9.02M derived: sum of 3 quarters · filed 2021-03-02 | $9.02M 10-K · filed 2021-03-02 | ||||||||||
| 2019-09-30 | -$568.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.02M derived: sum of 2 quarters · filed 2020-11-09 | $9.02M 10-Q · filed 2020-11-09 | $9.02M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||
| 2019-06-30 | $9.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.02M 10-Q · filed 2020-08-10 | $9.02M derived: sum of 3 quarters · filed 2020-08-10 | $24.14M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||
| 2019-03-31 | -$811.00 10-Q · filed 2020-05-07 | -$1.60K derived: sum of 2 quarters · filed 2020-05-07 | $15.12M derived: sum of 3 quarters · filed 2020-05-07 | $15.02M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||
| 2018-12-31 | -$790.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $15.12M derived: sum of 2 quarters · filed 2020-03-09 | $15.02M derived: sum of 3 quarters · filed 2020-03-09 | $15.02M 10-K · filed 2020-03-09 | ||||||||||
| 2018-09-30 | $15.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $15.02M derived: sum of 2 quarters · filed 2019-11-12 | $15.02M 10-Q · filed 2019-11-12 | $22.19M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||
| 2018-06-30 | -$93.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$94.62K 10-Q · filed 2019-08-12 | $7.08M derived: sum of 3 quarters · filed 2019-08-12 | $6.99M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||
| 2018-03-31 | -$728.00 10-Q · filed 2019-05-06 | $7.17M derived: sum of 2 quarters · filed 2019-05-06 | $7.09M derived: sum of 3 quarters · filed 2019-05-06 | $7.08M derived: sum of 4 quarters · filed 2019-05-06 | ||||||||||
| 2017-12-31 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $7.09M derived: sum of 2 quarters · filed 2019-02-26 | $7.08M derived: sum of 3 quarters · filed 2019-02-26 | $9.93M 10-K · filed 2019-02-26 | ||||||||||
| 2017-09-30 | -$81.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$88.97K derived: sum of 2 quarters · filed 2018-11-13 | $2.76M 10-Q · filed 2018-11-13 | $10.97M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||
| 2017-06-30 | -$7.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $2.84M 10-Q · filed 2018-08-10 | $11.05M derived: sum of 3 quarters · filed 2018-08-10 | |||||||||||
| 2017-03-31 | $2.85M 10-Q · filed 2018-05-11 | $11.06M derived: sum of 2 quarters · filed 2018-05-11 | ||||||||||||
| 2016-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $15.94M 10-K · filed 2018-03-21 | ||||||||||||
| 2016-09-30 | $7.73M 10-Q · filed 2017-11-09 | |||||||||||||
| 2013-09-30 | -$604.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$1.20K derived: sum of 2 quarters · filed 2013-11-13 | $5.04M 10-Q · filed 2013-11-13 | $7.88M derived: sum of 4 quarters · filed 2013-11-13 | $48.19M 10-Q · filed 2013-11-13 | |||||||||
| 2013-06-30 | -$594.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $5.04M 10-Q · filed 2013-08-12 | $7.88M derived: sum of 3 quarters · filed 2013-08-12 | $8.03M derived: sum of 4 quarters · filed 2013-11-13 | $48.19M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $5.05M 10-Q · filed 2013-05-15 | $7.88M derived: sum of 2 quarters · filed 2013-05-15 | $8.03M derived: sum of 3 quarters · filed 2013-11-13 | $12.90M derived: sum of 4 quarters · filed 2013-11-13 | $48.19M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $2.98M derived: sum of 2 quarters · filed 2013-11-13 | $7.85M derived: sum of 3 quarters · filed 2013-11-13 | $7.85M 10-K · filed 2013-03-28 | $43.14M 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | $150.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $5.02M derived: sum of 2 quarters · filed 2013-11-13 | $5.02M 10-Q · filed 2013-11-13 | $10.48M derived: sum of 4 quarters · filed 2013-11-13 | $40.31M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $4.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $4.87M 10-Q · filed 2013-08-12 | $10.33M derived: sum of 3 quarters · filed 2013-08-12 | $10.22M derived: sum of 4 quarters · filed 2013-08-12 | $40.16M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | -$544.00 10-Q · filed 2013-05-15 | $5.46M derived: sum of 2 quarters · filed 2013-05-15 | $5.35M derived: sum of 3 quarters · filed 2013-05-15 | $9.57M derived: sum of 4 quarters · filed 2013-05-15 | $35.29M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $5.35M derived: sum of 2 quarters · filed 2013-03-28 | $9.57M derived: sum of 3 quarters · filed 2013-03-28 | $9.52M 10-K · filed 2013-03-28 | $35.29M 10-K · filed 2012-03-09 | |||||||||
| 2011-09-30 | -$102.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $4.11M derived: sum of 2 quarters · filed 2012-11-06 | $4.06M 10-Q · filed 2012-11-06 | $4.46M derived: sum of 4 quarters · filed 2012-11-06 | $29.83M 10-Q · filed 2011-11-07 | |||||||||
| 2011-06-30 | $4.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.16M 10-Q · filed 2012-08-09 | $4.56M derived: sum of 3 quarters · filed 2012-08-09 | $4.52M derived: sum of 4 quarters · filed 2012-08-09 | $29.93M 10-Q · filed 2011-08-12 | |||||||||
| 2011-03-31 | -$50.51K 10-Q · filed 2012-05-04 | $350.00K derived: sum of 2 quarters · filed 2012-05-04 | $311.90K derived: sum of 3 quarters · filed 2012-05-04 | |||||||||||
| 2010-12-31 | $400.51K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $362.40K derived: sum of 2 quarters · filed 2012-03-09 | $3.08M 10-K · filed 2012-03-09 | |||||||||||
| 2010-09-30 | -$38.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $2.68M 10-Q · filed 2011-11-07 | ||||||||||||
| 2010-06-30 | $2.72M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |